Insight Molecular Diagnostics Inc
IMDX
NASDAQ
Biotechnology
$4.32
USD
+0.61 (+16.44%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $131.55M
Volume 331.6K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
OTLK | Outlook Therapeutics Inc | $163.15M | - | - | - | |
CBUS | Cibus Inc | $148.47M | - | -9.8% | - | |
SPRB | Spruce Biosciences, Inc | $136.98M | - | - | - | |
IMDX | Insight Molecular Diagnostics Inc | $131.55M | - | -49.3% | - | |
CUE | Cue Biopharma Inc | $131.26M | - | +309.6% | - | |
EQ | Equillium Inc | $127.40M | - | - | - | |
VTVT | vTv Therapeutics Inc | $125.18M | 55.59 | +216600.0% | - | |
GNLX | Genelux Corp | $121.97M | - | - | - | |
INDP | Indaptus Therapeutics Inc | $120.04M | - | - | - | |
BDTX | Black Diamond Therapeutics Inc | $116.92M | - | - | - |
Top Peer by Growth
vTv Therapeutics Inc
+216600.0% YoY Revenue
Lowest P/E Ratio
vTv Therapeutics Inc
55.59x P/E
Best 1-Year Return
Spruce Biosciences, Inc
+423.0% Return